Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Regeneron backs $75M series A for antibody upstart Infinimmune

Regeneron backs $75M series A for antibody upstart Infinimmune

August 10, 2026Posted inBiotechnology

Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm.

Post navigation

Previous Post
basemap-abe-launched-for-off-target-characterization-in-base-editing-therapeutic-development BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development
Next Post
Candida auris Persists in Hair Follicles, Hijacks Immune Signaling

Recent Posts

  • Molecular Clues Reveal Why Neuromas Cause Pain
  • Mount Sinai Reaches Milestone 2 in $101 Million XPRIZE Healthspan Competition
  • Trinity study: Steroids curb inflammation in mycobacterial lung disease without weakening immunity
  • AI Foundation Model Stratifies and Triages Acute Abdominal Diagnoses Using Noncontrast CT
  • Soft Robotic Cardiac Sleeves: Engineering Challenges and Clinical Translation for Heart Failure

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top